First Time Loading...

Sonoma Pharmaceuticals Inc
NASDAQ:SNOA

Watchlist Manager
Sonoma Pharmaceuticals Inc Logo
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Watchlist
Price: 0.227 USD -3.81% Market Closed
Updated: May 21, 2024

Sonoma Pharmaceuticals Inc
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Sonoma Pharmaceuticals Inc
Current Portion of Long-Term Debt Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Current Portion of Long-Term Debt
$2.3B
CAGR 3-Years
-10%
CAGR 5-Years
13%
CAGR 10-Years
-5%
Bristol-Myers Squibb Co
NYSE:BMY
Current Portion of Long-Term Debt
$2.9B
CAGR 3-Years
24%
CAGR 5-Years
N/A
CAGR 10-Years
26%
Pfizer Inc
NYSE:PFE
Current Portion of Long-Term Debt
$1B
CAGR 3-Years
-35%
CAGR 5-Years
-26%
CAGR 10-Years
-20%
Merck & Co Inc
NYSE:MRK
Current Portion of Long-Term Debt
$3.1B
CAGR 3-Years
-25%
CAGR 5-Years
-1%
CAGR 10-Years
-10%
Eli Lilly and Co
NYSE:LLY
Current Portion of Long-Term Debt
$1.7B
CAGR 3-Years
591%
CAGR 5-Years
-7%
CAGR 10-Years
68%

See Also